News Sentiment

IRTC sentiment intelligence

iRhythm Technologies Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 43 Balanced news tone 59 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 110.88 Week of 17 Jul 2026
Weighted tone 43/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

76/100 classification confidence.

Company focus 48

directly relevant articles

Source quality 3

high-authority source matches

Trend context Trend inactive

-4.5% over one week, +6.0% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Negative

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Investors to Learn More About the Investigation

Market Reaction

Price moving ahead of tone

65/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 76/100 classification
One-week reaction -4.5% Price reacting lower
Trend fit Trend inactive 6.0% over four weeks
Fair value -4.9% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 9
Neutral 33
Negative 17

Relevance

Why the article matched

Direct first
Direct company coverage 48
Industry context 11
Sector context 0

Sources

Coverage mix

Publishers
Market source 16
ACCESS Newswire 9
Stock Titan 6
Moomoo 4
simplywall.st 3
StockStory 3
Stock Traders Daily 2
Quartr 2

Event Lens

What the news is about

Classified themes
Market update 25
Earnings 20
Regulatory and legal 9
Analyst action 4
Macro sensitivity 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 59
ACCESS Newswire Direct company coverage

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Investors to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC has launched an investigation into potential corporate wrongdoing by iRhythm Technologies, Inc. (IRTC) and its officers/directors. Investors who purchased iRhythm securities before January 11, 2022, and still hold them, are encouraged to partici

Tone
Negative 19/100
Event
Regulatory and legal
Published
20 Jul 2026 21:10
Source
ACCESS Newswire
Stock Traders Daily Direct company coverage

Technical Reactions to IRTC Trends in Macro Strategies

This article provides a technical analysis of Irhythm Technologies Inc. (NASDAQ: IRTC), highlighting near-term weak sentiment that may lead to a resumption of long-term weakness. It identifies a significant risk-reward short setup and offers three distinct AI-generated trading st

Tone
Negative 38/100
Event
Market update
Published
19 Jul 2026 14:10
Source
Stock Traders Daily
The Globe and Mail Direct company coverage

Analysts Offer Insights on Healthcare Companies: Irhythm Technologies (IRTC), Merck & Company (MRK) and Viking Therapeutics (VKTX)

This article highlights recent bullish analyst ratings for three healthcare companies: Irhythm Technologies (IRTC), Merck & Company (MRK), and Viking Therapeutics (VKTX). Analysts from BTIG, Scotiabank, and Canaccord Genuity reiterated Buy ratings, providing price targets and not

Tone
Positive 71/100
Event
Analyst action
Published
17 Jul 2026 08:39
Source
The Globe and Mail
www.marketscreener.com Direct company coverage

IRhythm Holdings to Report Second Quarter 2026 Financial Results on August 6, 2026

iRhythm Holdings, Inc. announced it will release its second-quarter 2026 financial results after market close on Thursday, August 6, 2026. The company will host a conference call at 1:30 p.m. PT / 4:30 p.m. ET to discuss these results, with a live and archived webcast available o

Tone
Neutral 50/100
Event
Earnings
Published
16 Jul 2026 20:12
Source
www.marketscreener.com
Moomoo Direct company coverage

Truist Adjusts Price Target on IRhythm Technologies to $160 From $174, Maintains Buy Rating

Truist Securities has adjusted its price target for IRhythm Technologies (IRTC) to $160, down from the previous $174. Despite the reduction in the price target, the firm has decided to maintain its Buy rating on the company's stock. This indicates a continued positive outlook on

Tone
Negative 39/100
Event
Analyst action
Published
16 Jul 2026 19:39
Source
Moomoo
ACCESS Newswire Direct company coverage

iRhythm Technologies, Inc. (IRTC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC has launched an investigation into potential corporate wrongdoing by iRhythm Technologies, Inc. (NASDAQ:IRTC). The law firm encourages shareholders who purchased iRhythm securities before January 11, 2022, and still hold them, to contact them to

Tone
Negative 20/100
Event
Regulatory and legal
Published
16 Jul 2026 11:00
Source
ACCESS Newswire
ACCESS Newswire Direct company coverage

Bronstein, Gewirtz & Grossman, LLC Is Investigating iRhythm Technologies, Inc. (IRTC) And Encourages Investors to Connect

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against iRhythm Technologies, Inc. (NASDAQ: IRTC) for alleged corporate wrongdoing. The firm encourages investors who purchased iRhythm securities before January 11, 2022, and still hold them, to join the invest

Tone
Negative 19/100
Event
Market update
Published
15 Jul 2026 11:42
Source
ACCESS Newswire
ACCESS Newswire Direct company coverage

Bronstein, Gewirtz & Grossman, LLC Encourages iRhythm Technologies, Inc. (IRTC) Stockholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of iRhythm Technologies, Inc. (IRTC) purchasers who bought securities before January 11, 2022, and still hold them. The investigation focuses on whether iRhythm's officers and directors engaged in corp

Tone
Negative 18/100
Event
Regulatory and legal
Published
12 Jul 2026 18:11
Source
ACCESS Newswire
Quartr Direct company coverage

iRhythm Technologies (IRTC) Q4 2024 earnings summary

iRhythm Technologies reported strong Q4 2024 results with revenue up 24% year-over-year to $164.3 million and full-year revenue reaching $591.8 million, an increase of 20.1%. The company expanded its commercial reach in the U.S. ambulatory cardiac monitoring market and advanced i

Tone
Positive 71/100
Event
Earnings
Published
09 Jul 2026 06:40
Source
Quartr
AD HOC NEWS Direct company coverage

iRhythm Technologies focuses on long-term growth as cardiac monitoring demand expands

iRhythm Technologies is expanding its cardiac monitoring business with its digital Zio service, catering to a growing market for remote rhythm diagnostics. The company's strategy involves scaling its technology-enabled service model, which combines wearable sensors with cloud-bas

Tone
Neutral 50/100
Event
Macro sensitivity
Published
07 Jul 2026 20:54
Source
AD HOC NEWS
Simply Wall Street Direct company coverage

Does iRhythm (IRTC) Balancing a Revenue Beat With In-Line Guidance Recast Its AI Cardiac Story?

iRhythm Technologies reported a quarterly revenue beat, exceeding analyst expectations by 2.8%, while reaffirming full-year guidance in line with consensus for its AI-enabled Zio cardiac monitoring platform. Despite the revenue beat, the muted investor reaction suggests the marke

Tone
Neutral 50/100
Event
Earnings
Published
05 Jul 2026 16:12
Source
Simply Wall Street
ACCESS Newswire Direct company coverage

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against iRhythm Technologies, Inc. (IRTC) And Encourages Stockholders to Reach Out

Bronstein, Gewirtz & Grossman, LLC has initiated an investigation into iRhythm Technologies, Inc. (IRTC) concerning potential corporate wrongdoing by its officers and directors. The law firm is encouraging iRhythm stockholders who purchased securities prior to January 11, 2022, a

Tone
Negative 28/100
Event
Regulatory and legal
Published
05 Jul 2026 11:00
Source
ACCESS Newswire
Morningstar Direct company coverage

Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Halper Sadeh LLC, an investor rights law firm, is investigating whether officers and directors of iRhythm Technologies, Inc. (NASDAQ: IRTC) breached their fiduciary duties to shareholders. The firm encourages long-term shareholders of iRhythm stock to contact them to discuss pote

Tone
Negative 13/100
Event
Market update
Published
04 Jul 2026 15:39
Source
Morningstar
ACCESS Newswire Direct company coverage

Bronstein, Gewirtz & Grossman, LLC Is Investigating iRhythm Technologies, Inc. (IRTC) And Encourages Stockholders to Connect

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against iRhythm Technologies, Inc. (IRTC) for alleged corporate wrongdoing. The firm encourages iRhythm stockholders who purchased securities before January 11, 2022, and continue to hold them, to assist in the

Tone
Negative 14/100
Event
Market update
Published
03 Jul 2026 16:12
Source
ACCESS Newswire
Morningstar Direct company coverage

Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm

Kuehn Law, PLLC, a shareholder litigation law firm, is investigating iRhythm Technologies, Inc. (NASDAQ: IRTC) officers and directors for potential breaches of fiduciary duties. This investigation stems from a federal securities lawsuit alleging that iRhythm insiders misrepresent

Tone
Negative 20/100
Event
Regulatory and legal
Published
03 Jul 2026 15:10
Source
Morningstar
ACCESS Newswire Direct company coverage

iRhythm Technologies, Inc. (IRTC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against iRhythm Technologies, Inc. (IRTC) concerning possible corporate wrongdoing by its officers and/or directors. The law firm is encouraging investors who purchased iRhythm securities before January 11, 2022

Tone
Negative 31/100
Event
Regulatory and legal
Published
30 Jun 2026 11:00
Source
ACCESS Newswire
ACCESS Newswire Direct company coverage

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Stockholders to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC has launched an investigation into iRhythm Technologies, Inc. (IRTC) for potential corporate wrongdoing, focusing on investors who purchased securities before January 11, 2022, and still hold them. The firm encourages affected stockholders to le

Tone
Negative 8/100
Event
Regulatory and legal
Published
28 Jun 2026 19:09
Source
ACCESS Newswire
Stock Traders Daily Direct company coverage

Trading the Move, Not the Narrative: (IRTC) Edition

This article analyzes Irhythm Technologies Inc. (NASDAQ: IRTC), highlighting a potential shift in near-term positive sentiment and resistance testing. It outlines an exceptional short setup with a 71.5:1 risk-reward ratio, targeting 20.7% downside. The piece also details AI-gener

Tone
Negative 31/100
Event
Market update
Published
27 Jun 2026 05:38
Source
Stock Traders Daily
ACCESS Newswire Direct company coverage

Bronstein, Gewirtz & Grossman, LLC Is Investigating iRhythm Technologies, Inc. (IRTC) And Encourages Shareholders to Connect

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against iRhythm Technologies, Inc. (NASDAQ:IRTC) on behalf of investors who purchased securities before January 11, 2022, and continue to hold them. The investigation focuses on whether iRhythm and its officers

Tone
Negative 30/100
Event
Regulatory and legal
Published
26 Jun 2026 02:39
Source
ACCESS Newswire
Moomoo Direct company coverage

iRhythm Technologies | DEF 14A: Definitive information statements

This entry indicates the filing of a DEF 14A Definitive Information Statement by iRhythm Technologies. This document typically contains important information for shareholders regarding a company's annual meeting, including proposals to be voted on and details about executive comp

Tone
Neutral 50/100
Event
Market update
Published
25 Jun 2026 23:39
Source
Moomoo
Market source Direct company coverage

iRhythm Holdings (IRTC) Dropped Despite Posting Beat-And-Raise Results

Despite posting beat-and-raise results, iRhythm Holdings (IRTC) saw its stock drop, influenced by broader weakness in the healthcare equipment industry and investor rotation into cyclical and technology stocks. A US Department of Justice Civil Investigative Demand (DOJ CID) relat

Tone
Neutral 50/100
Event
Earnings
Published
25 Jun 2026 09:33
Source
Market source
Mugglehead Investment Magazine Direct company coverage

Cyberattacks on medtech companies become a frequent occurrence

Cyberattacks on medical technology companies are becoming increasingly common and sophisticated, targeting firms through methods like phishing and social engineering. iRhythm Technologies recently experienced a breach where data was stolen from third-party applications, prompting

Tone
Negative 29/100
Event
Market update
Published
22 Jun 2026 08:41
Source
Mugglehead Investment Magazine
Quartr Direct company coverage

iRhythm Technologies (IRTC) Truist Securities MedTech Conference 2026 Summary

iRhythm Technologies presented at the Truist Securities MedTech Conference 2026, where they discussed a recent cybersecurity incident, regulatory progress for Zio MCT, and advancements in their AI algorithm. The company confirmed no material financial impact from the cyber incide

Tone
Positive 64/100
Event
Regulatory and legal
Published
21 Jun 2026 21:10
Source
Quartr